Synaptotagmin 1 mediates toxicity of botulinum neurotoxin type A
Merja JoensuuiD, Parnayan SyediD, Saber H. SaberiD, Vanessa LanoueiD, Tristan P. WallisiD, James A. RaeiD, Ailisa BlumiD, Rachel S. GormaliD, Christopher SmalliD, Shanley F. LongfieldiD, Anmin JiangiD, Stefan Mahrhold, Nadja KreziD, Michael Alan CousiniD, Ruby Cooper‐White, Justin John Cooper-WhiteiD, Brett M. CollinsiD, Robert G. PartoniD, Giuseppe BalistreriiD, Andreas RummeliD, Frédéric A. MeunieriD
Abstract
The extreme neurotoxicity of botulinum neurotoxins (BoNTs), broadly used as a therapeutics, is mediated by their direct binding to two plasma membrane receptors: polysialogangliosides (PSGs) and serotype-dependently either synaptotagmin 1/2 (Syt1/2) or synaptic vesicle glycoprotein 2 (SV2). Here, we demonstrate that although BoNT/A serotype binds directly to PSG and SV2, its neurotoxicity depends on Syt1. Using single-molecule superresolution microscopy of pathological concentrations of BoNT/A holotoxins, we demonstrate that the toxin binds to a preassembled PSG-Syt1 complex that forms nanoclusters with SV2 on the plasma membrane of hippocampal neurons. This coincidental interaction controls the selective endocytic targeting of BoNT/A into synaptic vesicles, leading to incapacitation of neuronal communication. Our results suggest that Syt1-SV2 plasma membrane nanoclusters may acts as a common target for various BoNT serotypes. One-Sentence SummaryBoNT/A hijacks an intrinsic tripartite PSG-Syt1-SV2 endocytic sorting mechanism to incapacitate neuronal communication
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 34
- FWCI
- 5.75
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex
J. Ramirez-Franco, F. Azzaz, … O. EL FAR·bioRxiv·Oct 18, 2021
- Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER
Y. C. Jeremy, F. Tay, … F. A. Bard·bioRxiv·Oct 17, 2023
- Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors
Fodil Azzaz, Didier Hilaire, Jacques Fantini·bioRxiv·Jul 6, 2022
- Botulinum Neurotoxin A1 Signaling in Pain Modulation within Human Sensory Neurons
Katherin A. Gabriel, Kali Hankerd, … Theodore John Price·Journal of NeurochemistryPeer-reviewed·Sep 1, 2025
- Botulinum neurotoxin A modulates the axonal release of pathological tau in hippocampal neurons
Chiara Panzi, Sunaina Surana, … Giampietro Schiavo·ToxiconPeer-reviewed·Apr 8, 2023
- Structures of native SV2A reveal the binding mode for tetanus neurotoxin and anti-epileptic racetams
Stephan Schenck, Toon Laeremans, … Janine Denise Brunner·Nature CommunicationsPeer-reviewed·May 5, 2025